Home - HCC

HCC Is a Research Consortium

that provides shared resources and a collaborative environment for over 1,100 cancer researchers at 7 Harvard institutions. Learn more about HCC here

Information for HCC members and collaborators

Shared resources available to HCC members

Resources and initiatives for Massachusetts communities

Opportunities for training and career enhancement

Clinical Investigator Support and Trial Search Tool

Research Funding Opportunities

March 06, 2026 – Announcements
GI SPORE Announcement - Seeking Interest
Harvard Cancer Consortium (HCC) investigators plan to apply for a GI focused SPORE in September 2026.
March 04, 2026 – Announcements
HCC Welcomes New Leadership to the Bioinformatics Training Core
Newest Co-Director of the HCC Bioinformatics Training Core: Will Gammerdinger
January 29, 2026 – ETCTN
Announcement of Availability for Entinostat
CTEP is accepting Letters of Intent (LOIs) to conduct clinical studies using entinostat, a class I histone deacetylase (HDAC) inhibitor, which is being developed by CTEP as an anticancer agent.
January 27, 2026 – Announcements
2026 HCC Incubator Award Program Symposium
Event Date: February 26, 2026 (2:00 - 5:00PM) Location: Dana-Farber Cancer Institute, Smith 308-309